Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Duediligence33

T.GAU

Accounting Question

If there are any CPA out there could you answer how the financials will be...

April 2, 2018

T.GAU

RE:RE:RE:RE:Just interesting

Or 3. Just defer Red Kite debt to 2020 as planned in the March 15 CC and keep...

March 31, 2018

T.GAU

RE:RE:RE:Just interesting

They had a 300 million shelf prospectus They could have issued 210 million...

March 31, 2018

T.GAU

RE:Just interesting

So if GOLDFIELDS or their proxy were involved in the short position from last...

March 31, 2018

T.BB

RE:RE:RE:Article

Hi middle age I am old age and can tell you that the same half cup is either...

March 30, 2018

T.BB

Market Manipulation

I am dismayed by the overt Market manipulation by whoever last Friday it was...

March 30, 2018

APHA

Aphria - good and bad

Phase 1,2, 3 and 4 plan as outlined last year was very good Broken coast OK...

March 29, 2018

T.GAU

Asanko extremely UNDERVALUED

Relative to jr miner Auryn with no revenue or Orezone yet to build a mine or...

March 27, 2018

T.GAU

Realistic honest plan to greatness

I am willing the take the short pain for the long term GAIN H1 2018 END in a...

March 15, 2018

T.GAU

RE:RE:RE:RE:Some links...

The base shelf prospectus and corresponding shelf registration statement...

March 13, 2018

T.GAU

RE:RE:Some links...

My opinion is Red Kite financing by debentures or increase of existing loan I...

March 13, 2018

T.GAU

Cash buyout Offer for AKG ? ?

See this news http://thomcalandra.com/china-entity-takes-ghana-gold-stake/

March 12, 2018

DRGDF

Very Happy with the Financials

Production profits Increasing Glad I loaded up recently under $ 12.00 It...

March 8, 2018

T.ORE

RE:ORE's Valuation with PBV at 7 times

I have ORE and spoke to Management at PDAC today. The upcoming feasabilty...

March 6, 2018

T.GAU

Something brewing

This substantial accumulation at $ 1.07 and $ 1.14 is an obvious presage to...

March 6, 2018

T.GAU

Not a crash - Grossly Undervalued

The price to book value is .5 whereas other miners with less oz production...

February 27, 2018

T.GAU

RE:New presentation out

Looks more positive with improving mining metrics and Red Kite financing...

February 26, 2018

T.GAU

RE:RE:RE:AKG's net debt

Not to worry so much the management would rather do joint venture with Zijin...

February 15, 2018

T.GAU

RE:AKG's net debt

Increased production back to the previous guidance of 240,000 oz per year in...

February 15, 2018

T.GAU

Bright future for AKG

Last year the risks very more at $ 6.00 so now with improved plant function...

February 13, 2018

Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »